BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33395986)

  • 1. Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer's disease spectrum.
    Herdick M; Dyrba M; Fritz HJ; Altenstein S; Ballarini T; Brosseron F; Buerger K; Can Cetindag A; Dechent P; Dobisch L; Duezel E; Ertl-Wagner B; Fliessbach K; Dawn Freiesleben S; Frommann I; Glanz W; Dylan Haynes J; Heneka MT; Janowitz D; Kilimann I; Laske C; Metzger CD; Munk MH; Peters O; Priller J; Roy N; Scheffler K; Schneider A; Spottke A; Jakob Spruth E; Tscheuschler M; Vukovich R; Wiltfang J; Jessen F; Teipel S; Grothe MJ
    Neuroimage Clin; 2020; 28():102495. PubMed ID: 33395986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrum.
    Amaefule CO; Dyrba M; Wolfsgruber S; Polcher A; Schneider A; Fliessbach K; Spottke A; Meiberth D; Preis L; Peters O; Incesoy EI; Spruth EJ; Priller J; Altenstein S; Bartels C; Wiltfang J; Janowitz D; Bürger K; Laske C; Munk M; Rudolph J; Glanz W; Dobisch L; Haynes JD; Dechent P; Ertl-Wagner B; Scheffler K; Kilimann I; Düzel E; Metzger CD; Wagner M; Jessen F; Teipel SJ
    Neuroimage Clin; 2021; 29():102533. PubMed ID: 33360018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.
    Teipel SJ; Dyrba M; Ballarini T; Brosseron F; Bruno D; Buerger K; Cosma NC; Dechent P; Dobisch L; Düzel E; Ewers M; Fliessbach K; Haynes JD; Janowitz D; Kilimann I; Laske C; Maier F; Metzger CD; Munk MH; Peters O; Pomara N; Preis L; Priller J; Ramírez A; Roy N; Scheffler K; Schneider A; Schott BH; Spottke A; Spruth EJ; Wagner M; Wiltfang J; Jessen F; Heneka MT
    J Alzheimers Dis; 2022; 85(3):1267-1282. PubMed ID: 34924387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The corticotopic organization of the human basal forebrain as revealed by regionally selective functional connectivity profiles.
    Fritz HJ; Ray N; Dyrba M; Sorg C; Teipel S; Grothe MJ
    Hum Brain Mapp; 2019 Feb; 40(3):868-878. PubMed ID: 30311315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study.
    Grothe MJ; Labrador-Espinosa MA; Jesús S; Macías-García D; Adarmes-Gómez A; Carrillo F; Camacho EI; Franco-Rosado P; Lora FR; Martín-Rodríguez JF; Barberá MA; Pastor P; Arroyo SE; Vila BS; Foraster AC; Martínez JR; Padilla FC; Morlans MP; Aramburu IG; Ceberio JI; Vara JH; de Fábregues-Boixar O; de Deus Fonticoba T; Pascual-Sedano B; ; Kulisevsky J; Martínez-Martín P; Santos-García D; Mir P
    Parkinsonism Relat Disord; 2021 Jul; 88():68-75. PubMed ID: 34144230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline.
    Labrador-Espinosa MA; Silva-Rodríguez J; Reina-Castillo MI; Mir P; Grothe MJ
    Mov Disord; 2023 Oct; 38(10):1871-1880. PubMed ID: 37492892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.
    Daamen M; Scheef L; Li S; Grothe MJ; Gaertner FC; Buchert R; Buerger K; Dobisch L; Drzezga A; Essler M; Ewers M; Fliessbach K; Herrera Melendez AL; Hetzer S; Janowitz D; Kilimann I; Krause BJ; Lange C; Laske C; Munk MH; Peters O; Priller J; Ramirez A; Reimold M; Rominger A; Rostamzadeh A; Roeske S; Roy N; Scheffler K; Schneider A; Spottke A; Spruth EJ; Teipel SJ; Wagner M; Düzel E; Jessen F; Boecker H;
    J Alzheimers Dis; 2023; 95(3):1013-1028. PubMed ID: 37638433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease.
    Teipel SJ; Metzger CD; Brosseron F; Buerger K; Brueggen K; Catak C; Diesing D; Dobisch L; Fliebach K; Franke C; Heneka MT; Kilimann I; Kofler B; Menne F; Peters O; Polcher A; Priller J; Schneider A; Spottke A; Spruth EJ; Thelen M; Thyrian RJ; Wagner M; Düzel E; Jessen F; Dyrba M;
    J Alzheimers Dis; 2018; 64(3):801-813. PubMed ID: 29914027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic power of resting-state fMRI for detection of network connectivity in Alzheimer's disease and mild cognitive impairment: A systematic review.
    Ibrahim B; Suppiah S; Ibrahim N; Mohamad M; Hassan HA; Nasser NS; Saripan MI
    Hum Brain Mapp; 2021 Jun; 42(9):2941-2968. PubMed ID: 33942449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of APOE ε2 allele on basal forebrain functional connectivity in mild cognitive impairment.
    Liu X; Zeng Q; Luo X; Li K; Xu X; Hong L; Li J; Guan X; Xu X; Huang P; Zhang MM;
    CNS Neurosci Ther; 2023 Feb; 29(2):597-608. PubMed ID: 36468416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.
    Brueggen K; Dyrba M; Cardenas-Blanco A; Schneider A; Fliessbach K; Buerger K; Janowitz D; Peters O; Menne F; Priller J; Spruth E; Wiltfang J; Vukovich R; Laske C; Buchmann M; Wagner M; Röske S; Spottke A; Rudolph J; Metzger CD; Kilimann I; Dobisch L; Düzel E; Jessen F; Teipel SJ;
    J Neurol; 2019 Oct; 266(10):2465-2474. PubMed ID: 31227891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease.
    Skouras S; Falcon C; Tucholka A; Rami L; Sanchez-Valle R; Lladó A; Gispert JD; Molinuevo JL
    Neuroimage Clin; 2019; 22():101777. PubMed ID: 30913531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
    Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
    Elife; 2023 Jan; 12():. PubMed ID: 36607335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status.
    Li S; Daamen M; Scheef L; Gaertner FC; Buchert R; Buchmann M; Buerger K; Catak C; Dobisch L; Drzezga A; Ertl-Wagner B; Essler M; Fliessbach K; Haynes JD; Incesoy EI; Kilimann I; Krause BJ; Lange C; Laske C; Priller J; Ramirez A; Reimold M; Rominger A; Roy N; Scheffler K; Maurer A; Schneider A; Spottke A; Spruth EJ; Teipel SJ; Tscheuschler M; Wagner M; Wolfsgruber S; Düzel E; Jessen F; Peters O; Boecker H;
    J Alzheimers Dis; 2021; 79(2):493-509. PubMed ID: 33337359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease.
    Butler T; Harvey P; Deshpande A; Tanzi E; Li Y; Tsui W; Silver C; Fischer E; Wang X; Chen J; Rusinek H; Pirraglia E; Osorio RS; Glodzik L; de Leon MJ
    Neurobiol Aging; 2018 May; 65():201-205. PubMed ID: 29499501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD).
    Scheef L; Grothe MJ; Koppara A; Daamen M; Boecker H; Biersack H; Schild HH; Wagner M; Teipel S; Jessen F
    Neuroimage Clin; 2019; 21():101612. PubMed ID: 30555006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
    Richter N; David LS; Grothe MJ; Teipel S; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Onur OA; Kukolja J
    J Alzheimers Dis; 2022; 86(1):425-440. PubMed ID: 35068451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.